Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788162 | SCV000927185 | uncertain significance | not provided | 2017-03-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000802302 | SCV000942127 | uncertain significance | Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection | 2025-01-27 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 489 of the STAT2 protein (p.Pro489Leu). This variant is present in population databases (rs138681270, gnomAD 0.08%). This missense change has been observed in individual(s) with clinical features of primary immunodeficiency (PMID: 32135276). ClinVar contains an entry for this variant (Variation ID: 636365). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt STAT2 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000788162 | SCV003818103 | uncertain significance | not provided | 2022-09-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000788162 | SCV004133479 | uncertain significance | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | STAT2: PM2 |
Breakthrough Genomics, |
RCV000788162 | SCV005191853 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Al Jalila Children’s Genomics Center, |
RCV003117576 | SCV003798476 | likely risk allele | Susceptibility to severe COVID-19 | 2022-07-01 | no assertion criteria provided | research |